HomepageLAB • NASDAQ
add
Fluidigm
Vorige slotkoers
$Â 1,63
Dag-range
$Â 1,70 - $Â 2,14
Jaar-range
$Â 1,21 - $Â 3,04
Beurswaarde
606,78Â mln. USD
Gem. volume
1,39Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 44,97Â mln. | 77,27% |
Bedrijfskosten | 47,56Â mln. | 65,93% |
Netto inkomsten | -26,94Â mln. | -28,29% |
Netto winstmarge | -59,90 | 27,63% |
Winst per aandeel | -0,03 | 75,43% |
EBITDA | -17,93Â mln. | -126,32% |
Effectief belastingtarief | -0,44% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 366,33Â mln. | 184,31% |
Totale activa | 681,54Â mln. | 100,88% |
Totale passiva | 192,21Â mln. | 20,32% |
Totaal aandelenvermogen | 489,33 mln. | — |
Uitstaande aandelen | 372,26 mln. | — |
Koers-boekwaardeverhouding | 1,24 | — |
Rendement op activa | -8,74% | — |
Rendement op kapitaal | -10,30% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -26,94Â mln. | -28,29% |
Operationele kasstroom | -27,87Â mln. | -144,21% |
Kasstroom uit beleggingen | -30,88Â mln. | 38,14% |
Kasstroom uit financiering | -2,00K | 99,83% |
Nettomutatie in liquide middelen | -59,16Â mln. | 5,57% |
Vrije kasstroom | -13,22Â mln. | -1.074,34% |
Over
Standard BioTools Inc., previously known as Fluidigm Corp., offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations. Wikipedia
Opgericht
1999
Hoofdvestiging
Website
Werknemers
537